盆腔侵袭性纤维瘤病1例并文献复习
A Case of Pelvic Invasive Fibromatosis and Literature Review
DOI: 10.12677/ACM.2022.12121698, PDF,   
作者: 李宝健：济宁医学院临床医学院，山东 济宁；王长河, 周 静*：济宁市第一人民医院，山东 济宁
关键词: 盆腔侵袭性纤维瘤病；女性盆腔肿物；临床特点；诊断；手术；病例报告；Invasive Fibromatosis of Pelvis； Female Pelvic Tumor； Clinical Characteristics； Diagnosis； Operation； Case Report
摘要: 侵袭性纤维瘤病(invasive fibromatosis, AF)又称为硬纤维瘤病、韧带样纤维瘤病(desmoid-type fi-bromatosis, DT)，是一种罕见的成纤维细胞来源的肿瘤。AF主要表现为一种局部侵袭性强、不转移、少见恶变、容易复发的交界性肿瘤，发生于盆腔闭孔内者较少见。本文报告了一例盆腔闭孔侵袭性纤维瘤病的病例，并进行文献复习，总结该病的病因、临床特点、诊断及治疗，以期提高对AF的认识。
Abstract: Invasive fibromatosis is also called desmoid disease, desmoids-type fibromatosis, it is a rare tumor of fibroblast origin. AF is mainly manifested as a borderline tumor with easy recurrence, strong lo-cal invasion, no metastasis and rare malignant transformation. This paper reports the clinical fea-tures, diagnosis and operation of a case of pelvic invasive fibromatosis, and studies the literature in order to improve everyone’s understanding of AF.
文章引用：李宝健, 王长河, 周静. 盆腔侵袭性纤维瘤病1例并文献复习[J]. 临床医学进展, 2022, 12(12): 11794-11800. https://doi.org/10.12677/ACM.2022.12121698

参考文献

[1] 王宁, 郑浩, 朱泽斌, 等. 腹型侵袭性纤维瘤病7例临床分析[J]. 安徽医药, 2021, 25(5): 920-922.
[2] Sbaraglia, M., Bellan, E. and Dei, T.A. (2021) The 2020 WHO Classification of Soft Tissue Tumours: News and Perspectives. Pathologica, 113, 70-84. [Google Scholar] [CrossRef] 
[3] Penel, N., Coindre, J.M., Bonvalot, S., et al. (2016) Management of Desmoid Tumours: A Nationwide Survey of Labelled Reference Centre Networks in France. European Journal of Cancer, 58, 90-96. [Google Scholar] [CrossRef] [PubMed]
[4] van Broekhoven, D.L., Grunhagen, D.J., den Bakker, M.A., et al. (2015) Time Trends in the Incidence and Treatment of Extra-Abdominal and Abdominal Aggressive Fibromatosis: A Population-Based Study. Annals of Surgical Oncology, 22, 2817-2823. [Google Scholar] [CrossRef] [PubMed]
[5] Kasper, B., Strobel, P. and Hohenberger, P. (2011) Desmoid Tu-mors: Clinical Features and Treatment Options for Advanced Disease. Oncologist, 16, 682-693. [Google Scholar] [CrossRef] [PubMed]
[6] Hamada, S., Urakawa, H., Kozawa, E., et al. (2016) Charac-teristics of Cultured Desmoid Cells with Different CTNNB1 Mutation Status. Cancer Medicine, 5, 352-360. [Google Scholar] [CrossRef] [PubMed]
[7] Nieuwenhuis, M.H., Casparie, M., Mathus-Vliegen, L.M., et al. (2011) A Nation-Wide Study Comparing Sporadic and Familial Adenomatous Polyposis-Related Desmoid-Type Fibromatoses. International Journal of Cancer, 129, 256-261. [Google Scholar] [CrossRef] [PubMed]
[8] Escobar, C., Munker, R., Thomas, J.O., et al. (2012) Update on Desmoid Tumors. Annals of Oncology, 23, 562-569. [Google Scholar] [CrossRef] [PubMed]
[9] Siaudinyte, I., Spiliauskaite, S., Arlauskiene, A., et al. (2019) Rapid Growth of a Giant Intra-Abdominal Desmoid Tumor Diagnosed during Pregnancy. The American Surgeon, 85, e204-e207. [Google Scholar] [CrossRef] 
[10] Fiore, M., Coppola, S., Cannell, A.J., et al. (2014) Des-moid-Type Fibromatosis and Pregnancy: A Multi-Institutional Analysis of Recurrence and Obstetric Risk. The American Surgeon, 259, 973-978. [Google Scholar] [CrossRef] 
[11] Santti, K., Ihalainen, H., Ronty, M., et al. (2019) Estrogen Receptor Beta Expression Correlates with Proliferation in Desmoid Tumors. Journal of Surgical Oncology, 119, 873-879. [Google Scholar] [CrossRef] [PubMed]
[12] Kasper, B., Baumgarten, C., Garcia, J., et al. (2017) An Update on the Management of Sporadic Desmoid-Type Fibromatosis: A European Consensus Initiative between Sarcoma Patients Eu-roNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sar-coma Group (STBSG). Annals of Oncology, 28, 2399-2408. [Google Scholar] [CrossRef] [PubMed]
[13] Otero, S., Moskovic, E.C., Strauss, D.C., et al. (2015) Desmoid-Type Fibromatosis. Clinical Radiology, 70, 1038-1045. [Google Scholar] [CrossRef] [PubMed]
[14] 陈烨佳, 罗振东, 吴宏洲. 腹内型侵袭性纤维瘤病的CT表现及鉴别诊断[J]. 医学影像学杂志, 2019, 29(6): 1053-1055.
[15] Cassidy, M.R., Lefkowitz, R.A., Long, N., et al. (2020) Association of MRI T2 Signal Intensity with Desmoid Tumor Progression during Active Observation: A Retro-spective Cohort Study. The American Surgeon, 271, 748-755. [Google Scholar] [CrossRef] 
[16] Castellazzi, G., Vanel, D., Le Cesne, A., et al. (2009) Can the MRI Signal of Aggressive Fibromatosis Be Used to Predict Its Behavior? European Journal of Radiology, 69, 222-229. [Google Scholar] [CrossRef] [PubMed]
[17] 姚蓬, 李小军, 黎学兵. MRI诊断腹部侵袭性纤维瘤病的临床特点及其影像学表现分析[J]. 影像研究与医学应用, 2021, 5(18): 136-137.
[18] 吴红学, 邹力, 柯东, 等. 腹腔内侵袭性纤维瘤病临床治疗回顾[J]. 中国医药导报, 2018, 15(35): 106-109.
[19] 陈金湖, 叶青, 黄峰. 腹内型侵袭性纤维瘤病的临床特征及诊治分析[J]. 中国癌症杂志, 2018, 28(8): 622-626.
[20] 朱斌, 谢海伟, 杨小兵. 腹壁侵袭性纤维瘤病11例的临床特征及外科诊疗[J]. 江苏医药, 2016, 42(23): 2636-2637.
[21] Micke, O. and Seegenschmiedt, M.H. (2005) Radiation Therapy for Aggressive Fibromatosis (Desmoid Tumors): Results of a National Patterns of Care Study. International Journal of Radiation Oncology, Biology, Physics, 61, 882-891. [Google Scholar] [CrossRef] [PubMed]
[22] He, X.D., Zhang, Y.B., Wang, L., et al. (2015) Prognostic Fac-tors for the Recurrence of Sporadic Desmoid-Type Fibromatosis after Macroscopically Complete Resection: Analysis of 114 Patients at a Single Institution. European Journal of Surgical Oncology, 41, 1013-1019. [Google Scholar] [CrossRef] [PubMed]
[23] 李云泽, 赵文嫣, 乔雷, 等. 腹壁侵袭性纤维瘤14例诊治体会[J]. 中国医科大学学报, 2021, 50(8): 759-761.
[24] 杨明, 李仕晟, 杨新明. 手术联合放疗治疗头颈部侵袭性纤维瘤病12例报道及文献复习[J]. 中国耳鼻咽喉颅底外科杂志, 2012, 18(5): 361-363.
[25] Janssen, M.L., van Broekhoven, D.L., Cates, J.M., et al. (2017) Meta-Analysis of the Influence of Surgical Margin and Adjuvant Radio-therapy on Local Recurrence after Resection of Sporadic Desmoid-Type Fibromatosis. British Journal of Surgery, 104, 347-357. [Google Scholar] [CrossRef] [PubMed]
[26] Fiore, M., Rimareix, F., Mariani, L., et al. (2009) Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment. Annals of Surgical Oncol-ogy, 16, 2587-2593. [Google Scholar] [CrossRef] [PubMed]
[27] 周思成, 魏然, 裴炜, 等. 侵袭性纤维瘤病多学科综合诊疗研究进展[J]. 肿瘤防治研究, 2020, 47(11): 866-870.
[28] von Mehren, M., Kane, J.M., Bui, M.M., et al. (2020) NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021. Journal of the National Comprehensive Cancer Network, 18, 1604-1612. [Google Scholar] [CrossRef] [PubMed]
[29] 袁梦婷, 韩光. 侵袭性纤维瘤的靶向治疗进展[J]. 中国肿瘤临床, 2021, 48(13): 695-699.
[30] Szucs, Z., Messiou, C., Wong, H.H., et al. (2017) Pazopanib, a Promising Option for the Treatment of Aggressive Fibromatosis. Anticancer Drugs, 28, 421-426. [Google Scholar] [CrossRef] 
[31] 李炫昊, 刘庆军, 杜林栋. 盆腔侵袭性纤维瘤致输尿管狭窄1例报告并文献复习[J]. 现代泌尿外科杂志, 2010, 15(3): 210-211.
[32] Crago, A.M., Denton, B., Salas, S., et al. (2013) A Prognostic Nomogram for Prediction of Recurrence in Desmoid Fibromatosis. The American Surgeon, 258, 347-353. [Google Scholar] [CrossRef] 

为你推荐